Josep Carreras Leukaemia Research Institute
LightNews LightNews
banner
carrerasijc.bsky.social
Josep Carreras Leukaemia Research Institute
@carrerasijc.bsky.social
390 followers 120 following 120 posts
🔬 International research institute advancing studies on #leukaemia, #lymphoma, and other #hemopathies.

Centre of Exellence Severo Ochoa and @cerca.cat

🌐 Explore our work at https://www.carrerasresearch.org/en
Posts Replies Media Videos
Pinned
carrerasijc.bsky.social
Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jan 21
Meet the pioneering scientists behind the IJC's research! 🔬✨ We are pleased to present our Starter Pack introducing you to the leading researchers driving advancements in #leukaemia, #lymphoma, and other #hemopathies

Follow us for valuable insights into their pioneering work 👇

go.bsky.app/9rX1Tuw
carrerasijc.bsky.social
¿Qué avances científicos nos esperan en el ámbito del envejecimiento?

No te pierdas la mesa redonda “El reto de hacerse mayor” para descubrir cómo la ciencia está cambiando nuestra forma de envejecer.

📅 6 Nov, 18:30
📍 Auditorio @the_prbb BCN
🎟️ Entrada libre
👩‍🔬Moderado por @vrodillab.bsky.social
October 24, 2025 at 4:06 PM
carrerasijc.bsky.social
The Josep Carreras Institute made its mark at #BIOSPAIN2025!

Our team fostered key collaborations 🤝, shared new leadership initiatives 💡and reinforced IJC’s position as a leading centre in #BloodCancer research 🔬

🔗 www.carrerasresearch.org/en/news/the-...
October 23, 2025 at 8:11 AM
carrerasijc.bsky.social
We’re proud to host the 2nd @securedproject.bsky.social Demonstration Workshop at IJC on 3-4 December!

A unique opportunity for research, healthcare and cybersecurity experts to explore cutting-edge solutions for secure biomedical data processing.

Register here!🔗 secured-project.eu/2nd-demo-wor...
October 22, 2025 at 11:42 AM
Reposted by Josep Carreras Leukaemia Research Institute
vaquerolab.bsky.social
🚨 We are hiring!
A #Postdoc position is open in the Chromatin Biology Lab to work on Sirtuins & Leukemia 🧬
If you are up to the challenge join our @vaquerolab.bsky.social team at @CarrerasIJC.bsky.social
Apply here 👉 careers.carrerasresearch.org/jobs/6549033-v…

Sirtuins rule! 🦾
VAC_82_2025 - POSTDOCTORAL RESEARCHER (Chromatin biology laboratory) - Institut de Recerca contra la Leucèmia Josep Carreras
Join the Josep Carreras Leukaemia Research Institute and contribute to our mission of innovating and advancing the fight against leukaemia and other hematologic diseases.
https://careers.carrerasresearch.org/jobs/6549033-v…
October 4, 2025 at 9:20 AM
Reposted by Josep Carreras Leukaemia Research Institute
idibaps.bsky.social
IDIBAPS SEMINAR

Malignant transformation of the immune system and therapeutic solutions

📆6/10 15h
👨‍🔬Ari Melnick, @carrerasijc.bsky.social 
📍 Esteve Auditorium, CEK

👉https://f.mtr.cool/earftanszd
September 25, 2025 at 12:02 PM
carrerasijc.bsky.social
Our common goal: curing childhood leukaemia 🤝

The Josep Carreras Institute, the Josep Carreras Foundation and the Sant Joan de Déu Research Institute launch a joint programme to advance research into paediatric blood cancers 🔬

🔗 Read more: www.carrerasresearch.org/en/news/new-...
July 25, 2025 at 7:39 AM
carrerasijc.bsky.social
📢 La unidad de Comunicación del IJC ha sido acreditada como Unidad de Cultura Científica y de la Innovación (UCC+I) por #FECYT.

Un paso clave para seguir acercando la ciencia a la sociedad🔬

🔗 www.carrerasresearch.org/es/noticias/...
July 23, 2025 at 8:48 AM
carrerasijc.bsky.social
La Dra. Sònia Guil nos habla de su investigación en #SíndromeDeRett y del nuevo fármaco que están desarrollando con el objetivo de revertir sus síntomas.

No te pierdas su entrevista en 'A golpe de bit' en #RNE 📻

Escúchala aquí 👇
www.rtve.es/play/audios/...
QTX153, el fármaco español contra el Síndrome de Rett
El Síndrome de Rett es un trastorno genético neurológico poco frecuente que afecta a la forma en la que se desarrolla el cerebro.
www.rtve.es
July 21, 2025 at 11:09 AM
carrerasijc.bsky.social
Congratulations, Dr Obiols! 👩‍🔬

Mireia Obiols, researcher at the @jlsardinalab.bsky.social, has successfully defended her #PhD thesis today at the IJC Auditorium.

Proud of your dedication and hard work 💪
July 18, 2025 at 12:29 PM
carrerasijc.bsky.social
🚨New research by @jlsardinalab.bsky.social and Gemma Valcarcel published at Science Advances uses a CRISPR technology to control immune cell response to inflammation in the lab.

🔗 Read more: www.carrerasresearch.org/en/news/epig...
July 17, 2025 at 9:28 AM
carrerasijc.bsky.social
Last #YoungResearchers Seminars before the summer break!

👩‍🔬 Our talented researchers Mar Gusi (Maribel Parra's lab) and Alba Vidal (Anna Bigas' lab) gave excellent presentations yesterday, sharing their work to the rest of the IJC community.

We’ll be back in September with more inspiring seminars✨
July 16, 2025 at 7:00 AM
carrerasijc.bsky.social
📢 Registration open!

Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬

📅 06-07 November 2025
📍 Barcelona
More information ⬇️
senescel2025.senescel.org

Co-organised by IJC Group Leader Dr. Verónica Rodilla ‪@vrodillab.bsky.social‬
July 10, 2025 at 12:04 PM
carrerasijc.bsky.social
🧬 New research from Pablo Menéndez's lab presents a novel CAR-T cells therapy designed to target 2️⃣ specific markers of T-ALL: the CD1a and CCR9 proteins.

Preclinical results show high efficacy and safety in the lab.

🔗 carrerasresearch.org/en/news/a-ne...

🤝 ISS Aragon, OneChain Immunotherapeutics
July 8, 2025 at 11:05 AM
carrerasijc.bsky.social
El Dr. @manelesteller.bsky.social , de l’IJC, i el Dr. @macips01.bsky.social reben el premi Jaume Aiguader i Miró de l'Acadèmia de Ciències Mèdiques i de la Salut per “El secret de la vida eterna” 📖

🔗 www.carrerasresearch.org/ca/noticies/...
May 22, 2025 at 7:11 AM
carrerasijc.bsky.social
💬🔬 Yesterday we held another inspiring Group Leaders Seminar at the Josep Carreras Institute

Dr Tomàs Navarro and Dr Gaël Roué shared deep insights into the biology and treatment of B-Lymphomas 👏

Sharing science is key to moving forward together 🚀
May 21, 2025 at 8:01 AM
carrerasijc.bsky.social
This Friday, do not miss Dr Rouault-Pierre's Invited Lecture!

💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells"

🗓️ 23 May, 12pm CEST
📍IJC Auditorium
Online at 👉 us06web.zoom.us/webinar/regi...
May 20, 2025 at 2:43 PM
carrerasijc.bsky.social
🔬🌍 Today, on #ClinicalTrialsDay, we celebrate the power of research to save lives

A hopeful milestone: In a phase I clinical trial, our new CAR-T therapy has shown promising results in patients with a highly resistant lymphoma

📄 Read the full story: www.carrerasresearch.org/en/news/new-...
May 20, 2025 at 9:32 AM
carrerasijc.bsky.social
Yesteday we officially welcomed Dr Ari Melnick, the new Director of the Josep Carreras Institute.

💬 "I see us as a team united in our purpose to eradicate blood cancers."

He reaffirmed his commitment to scientific progress and collaborative growth in front of #IJC community 🚀
May 14, 2025 at 9:31 AM
carrerasijc.bsky.social
New study co-led by @manelesteller.bsky.social shows that epigenetic profiling identifies two distinct subtypes of Burkitt lymphoma, allowing early prediction of disease aggressiveness. This could help tailor treatment strategies from diagnosis. 🧬📈

👉 www.carrerasresearch.org/en/news/epig...
Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries
Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common...
www.carrerasresearch.org
May 14, 2025 at 9:29 AM
carrerasijc.bsky.social
❗️🔬 New research from @scuartero.bsky.social's lab reveals that CEBPA mutations in #AML increase resistance to inflammation but make cells more vulnerable to protein-folding stress, opening the door to new treatment strategies.

➡️ www.carrerasresearch.org/en/news/a-co...
May 5, 2025 at 11:50 AM
carrerasijc.bsky.social
New CD30-targeted CAR-T therapy shows 100% overall response and 50% complete remission in Refractory Hodgkin Lymphoma patients

👉 carrerasresearch.org/en/news/new-...

🔬 Led by Dr. Javier Briones, PI at #IJC and @irsantpau.bsky.social @hospitalsantpau.bsky.social

📝 @bloodjournal.bsky.social
April 29, 2025 at 1:24 PM
carrerasijc.bsky.social
We're pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Institute.

Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases.

Read the full release here: www.carrerasresearch.org/en/news/dr-a...
April 22, 2025 at 2:05 PM
carrerasijc.bsky.social
🧬 Genetic susceptibility to cancer explained.

New study by Eduard Porta's lab at @cellpress.bsky.social describes 119 germline variants with significant contribution to cancer onset and progession.

➡️ carrerasresearch.org/en/news/new-...
April 15, 2025 at 8:06 AM
carrerasijc.bsky.social
Next week, we’re honoured to welcome to IJC Dr. Rainer Storb, a world-leading expert in haematology.

"History of Allogeneic Hematopoietic Cell Transplantation as an Example of Intensive Bench-to-Bedside Research"
🗓️ 24 April - 12pm
📍 IJC Auditorium +Online
🔗 www.carrerasresearch.org/en/events/hi...
April 14, 2025 at 8:39 AM
carrerasijc.bsky.social
La Dra. @bmjavierre.bsky.social ha sido reconocida con el prestigioso Premio CRIS Excelencia de #CRISContraElCáncerr 🏆

Gracias al programa, su grupo estudiará cómo el ADN 🧬se ve alterado en el tratamiento de la leucemia linfoblástica de células B y cómo esto puede llevar a recaídas.
April 11, 2025 at 1:34 PM